<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Chemistry</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/136DED6D-E7F0-4C3D-AF00-E7FECA1DFB63"><gtr:id>136DED6D-E7F0-4C3D-AF00-E7FECA1DFB63</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Bradley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A795188F-66D2-4CB7-BCCE-4E65A775618A"><gtr:id>A795188F-66D2-4CB7-BCCE-4E65A775618A</gtr:id><gtr:firstName>Tim</gtr:firstName><gtr:surname>Elliott</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401194"><gtr:id>3E74E42B-9835-4DA7-BC31-92C9A505B807</gtr:id><gtr:title>HT Chemical Biology - Transfection Microarrays and Combinatorial Chemistry.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401194</gtr:grantReference><gtr:abstractText>Teaching and training courses
Schools lectures and lecture at the BAAS
Work-shadowing within group</gtr:abstractText><gtr:technicalSummary>This research proposal, aimed at the development and exploitation of ?Transfection Arrays? combines the strengths of two research groups, one based in one in combinatorial chemistry and HT chemical biology and one in cancer research. This research proposal is aimed at the development of transfection micro-arrays that can be rapidly and efficiently screened against any cell type or line of choice, thereby allowing the rapid and optimal selection of cell-specific transfection agents. Specific objectives of the proposal are: The preparation, by solid-phase synthesis, of libraries transfection lipids and dendrimers (2-5000 compounds). The fabrication of so-called ?Transfection Chips? and the exploitation of these chips for optimization of transfection for a wide variety of cell lines and cell types (including primary), and the introduction of both DNA and RNAi into cells, tied in with the development of HT data analysis platforms for rapid array analysis.
This proposal targets important areas of medical research in the identification of new targets, antigen discovery and an under-standing gene function. Research will be applied and exploited in a broad number of settings, indeed the aim is to make this the method of choice for the identification of specific transfection parameters and to allow HT gene delivery.</gtr:technicalSummary><gtr:fund><gtr:end>2008-07-07</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-07-08</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>284982</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Technology Lincesing Opportunities</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>6A8FFA1D-0C11-4FDA-AD9F-7FED4BE1878D</gtr:id><gtr:impact>The novel gene transfer reagents developed (and protected under a UK and a PCT patent application) were disseminated via the Edinburgh Research and Innovation (online and press). Several companies such as GE healthcare, Millipore and BioRad showed great interest in obtaining technology licenses of our product.

This dissemination provided two assessment licenses: one with GE healthcare and another with BioRad.</gtr:impact><gtr:outcomeId>B902E779A74</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>189515</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Proof of Concept programme (Scottish Entreprise)</gtr:description><gtr:end>2010-11-02</gtr:end><gtr:fundingOrg>Scottish Enterprise</gtr:fundingOrg><gtr:id>6E5B944B-BC6B-4A28-BCEA-7F613647A742</gtr:id><gtr:outcomeId>E9C9D7589FF0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (Multiplexed in vivo optimisation of non-toxic gene transfer agents)</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>11061CEA-4F3A-47D2-9228-EE1B47150E17</gtr:id><gtr:outcomeId>9671F72A0850</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>New transfection reagent</gtr:description><gtr:grantRef>G0401194</gtr:grantRef><gtr:id>1E352782-F58A-4A22-AC78-F7EEF2F2AF29</gtr:id><gtr:impact>basis of spin-out company</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>Sv2mKRZr9xS</gtr:outcomeId><gtr:patentId>WO2009050483</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Patent of new transfection reagents</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Transfection reagent</gtr:description><gtr:id>C400B593-676F-4FAB-A602-13641B39EA47</gtr:id><gtr:impact>better than all other materials</gtr:impact><gtr:outcomeId>EFB1C589F7D</gtr:outcomeId><gtr:stage>Market authorisation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>New transfection reagent</gtr:title><gtr:type>Support Tool - For Fundamental Research</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New Transfection reagent</gtr:description><gtr:id>51BBBBE6-9D03-485A-BD4E-1541241ED646</gtr:id><gtr:impact>brilliant new transfection reagent for in vitro and in vivo application</gtr:impact><gtr:outcomeId>56120E1DC34</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SAFECTIN</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Deliverics</gtr:companyName><gtr:description>Deliverics.com</gtr:description><gtr:id>C8D45BBC-907A-4199-946A-9D514D589464</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>V5Co16UZ947</gtr:outcomeId><gtr:url>http://www.deliverics.com/home/</gtr:url><gtr:yearCompanyFormed>2010</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>0ED62075-C9DE-4291-A9A2-597A8BD3078B</gtr:id><gtr:title>Tripod-like cationic lipids as novel gene carriers.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdffa356b4e030994b5d63c62e890fe4"><gtr:id>bdffa356b4e030994b5d63c62e890fe4</gtr:id><gtr:otherNames>Unciti-Broceta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>1FDA5FD0D2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>073C46F6-2CC3-425E-B18A-ACD9007EFB53</gtr:id><gtr:title>Solid-phase synthesis of a lysine-capped bis-dendron with remarkable DNA delivery abilities.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1c537b352f5c8b5a84dbc1bc7e2a958"><gtr:id>a1c537b352f5c8b5a84dbc1bc7e2a958</gtr:id><gtr:otherNames>How SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>3474676BA23</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE988C8E-C4EF-43E6-B2CE-122A904F4DBF</gtr:id><gtr:title>Combining nebulization-mediated transfection and polymer microarrays for the rapid determination of optimal transfection substrates.</gtr:title><gtr:parentPublicationTitle>Journal of combinatorial chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdffa356b4e030994b5d63c62e890fe4"><gtr:id>bdffa356b4e030994b5d63c62e890fe4</gtr:id><gtr:otherNames>Unciti-Broceta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1520-4766</gtr:issn><gtr:outcomeId>18BB4F6A53F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>480AFC24-3F7A-41EC-B40A-C1F813AD1625</gtr:id><gtr:title>Synthesis, penetrability and intracellular targeting of fluorescein-tagged peptoids and peptide-peptoid hybrids.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdffa356b4e030994b5d63c62e890fe4"><gtr:id>bdffa356b4e030994b5d63c62e890fe4</gtr:id><gtr:otherNames>Unciti-Broceta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn><gtr:outcomeId>C85E3610ECD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>768C1E94-79F2-4E5C-871F-16ECF8DBE514</gtr:id><gtr:title>A yeast chemical genetic screen identifies inhibitors of human telomerase.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6405e7f0bcae0bcb843f5cea251d1221"><gtr:id>6405e7f0bcae0bcb843f5cea251d1221</gtr:id><gtr:otherNames>Wong LH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>doi_55f9839839411a93</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1822B9DD-0F94-4B6D-8C5F-68CB4FDE54CE</gtr:id><gtr:title>Deciphering cellular morphology and biocompatibility using polymer microarrays.</gtr:title><gtr:parentPublicationTitle>Biomedical materials (Bristol, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c4029080e1f96de47e75af282edbe4"><gtr:id>32c4029080e1f96de47e75af282edbe4</gtr:id><gtr:otherNames>Pernagallo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1748-6041</gtr:issn><gtr:outcomeId>0C26594C717</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401194</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8EA3EC93-8E9C-482F-8121-C6C8413D9B6D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.3  Chemical and physical sciences</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>